SOLVO Biotechnology introduces Predicell™ for OATP1B3, OATP1B1 and OCT2

March 11, 2011

SOLVO proudly introduces PREDICELLTM, the world’s first commercially available ready-to-use uptake transporter assay kits for OATP1B3, OATP1B1 and OCT2.
  • Perform uptake transporter studies in-house
  • Run uptake assays without cell culturing
  • Access to uptake transporters without cell line development or licensing
  • The assays are available
  • 96-well kit for inhibition studies
  • 24-well kit for direct uptake studies (substrate assessment)
The kits can be transported at room temperature and are stable for 48 hours. Technical support is provided at any steps. Learn more about the Predicell uptake transporter assay kits.

Next entry: The Revolutionary Ready-to-use Transfected MDCKII Monolayer System is Now Available for BCRP

Previous entry: SOLVO Hosts DMDG Spring Meeting in Budapest between 24-25 March 2011

More News

Read all news in the archive